【24h】

HCV serotypes in Brazilian patients

机译:巴西患者的HCV血清型

获取原文
           

摘要

Objective: To investigate the prevalence of the different types of hepatitis C virus (HCV) in a population of chronic HCV carriers using the Murex HCV serotyping 1-6 assay. Methods: All serum samples from these patients had a positive nested PCR HCV reaction. The sera were submitted to ELISA, modified, for the identification of antibodies against HCV serotypes 1, 2, 3, 4, 5 and 6 (Murex HCV serotyping 1-6 assay). Results: The viral serotype was identified in 166 (75.8%) of the 219 patients, 108 (65.11%) males and 58 (34.9%) females. Patient age ranged from 12 to 73 years, with a mean of 41.1 years. The form of acquisition of the disease most frequently reported was blood transfusion. The results showed a predominance of type 1 (70.0%), followed by type 3 (22.3%) and type 2 (4.2%). Conclusion: Samples presenting low and very close optical density readings may lead to discrepant diagnoses concerning HCV serotypes and should be confirmed by genotyping. The serotyping can be useful in clinical practice and can be of help in establishing the prognosis of the disease, also favoring epidemiologic studies independently of the technology required for genotyping tests.
机译:目的:使用Murex HCV血清分型1-6分析法研究慢性HCV携带者人群中不同类型的丙型肝炎病毒(HCV)的患病率。方法:这些患者的所有血清样品的巢式PCR HCV反应均为阳性。将血清送交ELISA修改,以鉴定针对HCV血清型1、2、3、4、5和6的抗体(Murex HCV血清型1-6检测)。结果:在219例患者中,有166名(75.8%)的病毒血清型被发现,其中男性108例(65.11%),女性58例(34.9%)。患者年龄为12至73岁,平均41.1岁。最常报告的疾病获得形式是输血。结果显示,类型1(70.0%),其次是类型3(22.3%)和类型2(4.2%)占优势。结论:光密度读数低且非常接近的样品可能会导致有关HCV血清型的错误诊断,应通过基因分型确诊。血清分型在临床实践中可能有用,并且有助于确定疾病的预后,也有利于流行病学研究,而与基因分型测试所需的技术无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号